World's Best Scientists 2026 revealed!
Lawrence H. Schwartz

Lawrence H. Schwartz

D-Index & Metrics

Medicine

D-Index
119
Citations
106067
World Ranking
3798
National Ranking
2084

Lawrence H. Schwartz publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Lawrence H. Schwartz sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 527 publications — 62nd percentile

62% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Lawrence H. Schwartz D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Lawrence H. Schwartz sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 119 D-Index — 81st percentile

81% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Research.com Recognitions

  • Member of the Association of American Physicians
  • Member of the Association of American Physicians

Overview

Lawrence H. Schwartz is affiliated with Columbia University in the United States. Their research spans primarily within the field of Medicine, with a strong emphasis on Radiology, Nuclear Medicine, and Imaging among other subfields.

The scientist has contributed extensively to oncology-related topics, especially within the domains of Radiomics and Machine Learning in Medical Imaging, Cancer Immunotherapy and Biomarkers, and Medical Imaging Techniques and Applications. Other highlighted topics in their work include Advanced X-ray and CT Imaging, Lung Cancer Treatments and Mutations, Lung Cancer Diagnosis and Treatment, and Cancer Genomics and Diagnostics.

Notable recent papers authored or co-authored by Lawrence H. Schwartz include:

  • Identification of Non-Small Cell Lung Cancer Sensitive to Systemic Cancer Therapies Using Radiomics, 2020, Clinical Cancer Research
  • Radiomics Response Signature for Identification of Metastatic Colorectal Cancer Sensitive to Therapies Targeting EGFR Pathway, 2020, JNCI Journal of the National Cancer Institute
  • Alliance A021501: Preoperative mFOLFIRINOX or mFOLFIRINOX plus hypofractionated radiation therapy (RT) for borderline resectable (BR) adenocarcinoma of the pancreas., 2021, Journal of Clinical Oncology
  • Artificial Intelligence and Early Detection of Pancreatic Cancer, 2021, Pancreas
  • Toward Generalizability in the Deployment of Artificial Intelligence in Radiology: Role of Computation Stress Testing to Overcome Underspecification, 2021, Radiology Artificial Intelligence

Frequent collaborators with Lawrence H. Schwartz include:

  • Laurent Dercle
  • Binsheng Zhao
  • Hao Yang
  • Lin Lü
  • Susan E. Bates

The scientist's work is commonly published in several prominent venues, with a significant number of papers in:

  • Journal of Clinical Oncology
  • European Radiology
  • Blood
  • Tomography
  • Journal for ImmunoTherapy of Cancer

Lawrence H. Schwartz's research intersects multiple medical disciplines, focusing on the applications of advanced imaging technologies and artificial intelligence in cancer diagnosis, treatment strategies, and biomarker identification. Their contributions cover substantial ground in imaging science as it applies to oncology and respiratory medicine.

They have been recognized as a Member of the Association of American Physicians.

Best Publications

  • New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)

    Elizabeth Eisenhauer;Patrick Therasse;Jan Bogaerts;L.H. Schwartz

  • The Multimodal Brain Tumor Image Segmentation Benchmark (BRATS)

    Bjoern H. Menze;Andras Jakab;Stefan Bauer;Jayashree Kalpathy-Cramer

  • Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano Classification

    Bruce D. Cheson;Richard I. Fisher;Sally F. Barrington;Franco Cavalli

  • The Lung Image Database Consortium (LIDC) and Image Database Resource Initiative (IDRI): a completed reference database of lung nodules on CT scans.

    Samuel G. Armato;Geoffrey McLennan;Luc Bidaut;Michael F. McNitt-Gray

  • Artificial intelligence in radiology

    Ahmed Hosny;Chintan Parmar;John Quackenbush;Lawrence H. Schwartz;Lawrence H. Schwartz

  • iRECIST: guidelines for response criteria for use in trials testing immunotherapeutics

    Lesley Seymour;Jan Bogaerts;Andrea Perrone;Robert Ford

  • Use of Positron Emission Tomography for Response Assessment of Lymphoma: Consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma

    Malik E. Juweid;Sigrid Stroobants;Otto S. Hoekstra;Felix M. Mottaghy

  • Phase II Study of Sorafenib in Patients With Advanced Hepatocellular Carcinoma

    Ghassan K. Abou-Alfa;Lawrence Schwartz;Sergio Ricci;Dino Amadori

  • RECIST 1.1—Update and clarification: From the RECIST committee

    Lawrence H. Schwartz;Lawrence H. Schwartz;Saskia Litiere;Elisabeth G. E. de Vries;Robert Ford

  • Cetuximab Shows Activity in Colorectal Cancer Patients With Tumors That Do Not Express the Epidermal Growth Factor Receptor by Immunohistochemistry

    Ki Young Chung;Jinru Shia;Nancy E. Kemeny;Manish Shah

  • Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3

    Howard I. Scher;Michael J. Morris;Walter M. Stadler;Celestia Higano

  • Phase I Study of an Oral Histone Deacetylase Inhibitor, Suberoylanilide Hydroxamic Acid, in Patients With Advanced Cancer

    William Kevin Kelly;Owen A. O'Connor;Lee M. Krug;Judy H. Chiao

  • Artificial intelligence in cancer imaging: Clinical challenges and applications.

    Wenya Linda Bi;Ahmed Hosny;Matthew B. Schabath;Maryellen L. Giger

  • Prognostic Factors for Survival in Previously Treated Patients With Metastatic Renal Cell Carcinoma

    Robert J. Motzer;Jennifer Bacik;Lawrence H. Schwartz;Victor Reuter

  • Phase I clinical trial of histone deacetylase inhibitor: Suberoylanilide hydroxamic acid administered intravenously

    Wm. Kevin Kelly;Wm. Kevin Kelly;Victoria M. Richon;Owen O’Connor;Tracy Curley

  • Intrahepatic cholangiocarcinoma: rising frequency, improved survival, and determinants of outcome after resection.

    Itaru Endo;Mithat Gonen;Adam C. Yopp;Kimberly M. Dalal

  • Deep inspiration breath-hold technique for lung tumors: the potential value of target immobilization and reduced lung density in dose escalation ☆

    Joseph Hanley;Marc M. Debois;Dennis Mah;Gikas S. Mageras

  • Circulating Tumor Cell Number and Prognosis in Progressive Castration-Resistant Prostate Cancer

    Daniel C. Danila;Glenn Heller;Gretchen A. Gignac;Rita Gonzalez-Espinoza

  • Phase II Study of Sorafenib in Patients With Metastatic or Recurrent Sarcomas

    Robert G. Maki;David R. D'Adamo;Mary L. Keohan;Michael Saulle

  • NCCN clinical practice guidelines in oncology: kidney cancer.

    Robert J Motzer;Neeraj Agarwal;Clair Beard;Graeme B Bolger

Frequent Co-Authors

Yuman Fong
Yuman Fong City Of Hope National Medical Center
Mithat Gonen
Mithat Gonen Memorial Sloan Kettering Cancer Center
William R. Jarnagin
William R. Jarnagin Memorial Sloan Kettering Cancer Center
Mark G. Kris
Mark G. Kris Memorial Sloan Kettering Cancer Center
Michael I. D’Angelica
Michael I. D’Angelica Memorial Sloan Kettering Cancer Center
Hedvig Hricak
Hedvig Hricak Memorial Sloan Kettering Cancer Center
Ghassan K. Abou-Alfa
Ghassan K. Abou-Alfa Memorial Sloan Kettering Cancer Center
Eileen M. O’Reilly
Eileen M. O’Reilly Memorial Sloan Kettering Cancer Center
Ronald P. DeMatteo
Ronald P. DeMatteo University of Pennsylvania
Michael J. Morris
Michael J. Morris Memorial Sloan Kettering Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in healthcare doesn’t always mean attending medical school. Many students consider direct entry msn programs as a fast track for non-nurses to enter advanced practice nursing without a prior nursing degree. This option is ideal for those who hold a bachelor’s degree in a different field and wish to make a career change.

If you’re looking for accessible pathways, online adn programs allow students to pursue an Associate Degree in Nursing remotely, making it easier for busy adults to start their nursing journey.

For those interested in non-clinical roles, there are reputable medical billing and coding financial aid programs that support students pursuing certificates or degrees in medical administration from accredited online schools.

Furthermore, some nursing schools that don't require teas or hesi exams can help streamline the application process, removing extra testing barriers for prospective students.

These flexible online education options open various career pathways in healthcare, catering to diverse backgrounds and interests.

Best Scientists Citing Lawrence H. Schwartz

Trending Scientists

Recently Published Articles